Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Breast ; 15(4): 482-9, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16403632

RESUMO

Tumor markers are expressed due to molecular alterations of the tumor cells, and we can relate them to the immune system to find new associations to improve prognosis. IL-10 inhibits the generation of immune responses at the tumor site. To determine IL-10 expression in the tumor microenvironment and to associate it with certain tumor markers, 27 breast cancer patients were monitored by immunohistochemistry. The results showed that 23 breast cancer samples exhibited a strong expression of IL-10. IL-10 was associated with some poor prognosis tumor makers. A direct association between IL-10, Bcl-2, and Bax was detected. The relationship between IL-10 and Bax was statistically significant (P=0.001). An inverse association of IL-10 with p53 was observed. IL-10 reflects a suppressive tumor microenvironment, and its relationship with apoptosis markers can suggest an increase in the aggressiveness of the tumor even if it still is at an early stage.


Assuntos
Biomarcadores Tumorais/sangue , Neoplasias da Mama/sangue , Interleucina-10/sangue , Adulto , Idoso , Idoso de 80 Anos ou mais , Apoptose/imunologia , Neoplasias da Mama/imunologia , Carcinoma Ductal de Mama/sangue , Feminino , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Prognóstico , Proteínas Proto-Oncogênicas c-bcl-2/sangue , Receptor ErbB-2/sangue , Receptores de Estrogênio/sangue , Proteína Supressora de Tumor p53/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA